Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
4.53
1.23 (37.27%)
At close: Sep 25, 2025, 3:59 PM
4.38
-3.31%
After-hours: Sep 25, 2025, 05:28 PM EDT
37.27% (1D)
| Bid | 4.46 |
| Market Cap | 28.61M |
| Revenue (ttm) | 3.19M |
| Net Income (ttm) | -11.98M |
| EPS (ttm) | -6.5 |
| PE Ratio (ttm) | -0.7 |
| Forward PE | -2.4 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.48 |
| Volume | 76,645,379 |
| Avg. Volume (20D) | 92,139 |
| Open | 4.67 |
| Previous Close | 3.30 |
| Day's Range | 3.91 - 4.75 |
| 52-Week Range | 1.20 - 16.10 |
| Beta | 0.14 |
| Ex-Dividend Date | n/a |
About EVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 hours ago
Evaxion shares are trading higher after the compan...
Unlock content with
Pro Subscription
1 month ago
-5.92%
Evaxion shares are trading lower after the company reported a year-over-year decrease in Q2 sales results.
